Concepts (72)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lysine | 2 | 2026 | 78 | 1.750 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2026 | 110 | 1.710 |
Why?
|
| Histone Deacetylase 6 | 1 | 2026 | 8 | 0.940 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2026 | 30 | 0.930 |
Why?
|
| Solute Carrier Organic Anion Transporter Family Member 1B3 | 1 | 2026 | 21 | 0.930 |
Why?
|
| Dendrimers | 3 | 2019 | 15 | 0.790 |
Why?
|
| Drug Delivery Systems | 4 | 2020 | 236 | 0.700 |
Why?
|
| Gene Silencing | 1 | 2017 | 65 | 0.490 |
Why?
|
| Nanoparticles | 5 | 2020 | 292 | 0.490 |
Why?
|
| Biological Transport | 3 | 2026 | 128 | 0.480 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 198 | 0.470 |
Why?
|
| Acetylation | 2 | 2026 | 41 | 0.450 |
Why?
|
| HEK293 Cells | 2 | 2026 | 202 | 0.430 |
Why?
|
| Neoplasms | 3 | 2021 | 887 | 0.250 |
Why?
|
| Anilides | 1 | 2026 | 24 | 0.240 |
Why?
|
| Hydroxamic Acids | 1 | 2026 | 22 | 0.240 |
Why?
|
| Hepatocytes | 1 | 2026 | 97 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 686 | 0.210 |
Why?
|
| Proteomics | 1 | 2026 | 200 | 0.200 |
Why?
|
| Humans | 11 | 2026 | 29202 | 0.200 |
Why?
|
| Phosphorylation | 1 | 2024 | 586 | 0.200 |
Why?
|
| Albumins | 2 | 2019 | 12 | 0.190 |
Why?
|
| Nanomedicine | 2 | 2020 | 62 | 0.190 |
Why?
|
| Animals | 8 | 2026 | 10802 | 0.190 |
Why?
|
| Permeability | 2 | 2019 | 61 | 0.180 |
Why?
|
| Podocytes | 1 | 2021 | 13 | 0.170 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 21 | 0.170 |
Why?
|
| Biosimilar Pharmaceuticals | 1 | 2021 | 4 | 0.170 |
Why?
|
| Drug Resistance, Multiple | 1 | 2020 | 20 | 0.160 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2019 | 1 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2019 | 47 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 172 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 216 | 0.140 |
Why?
|
| Exosomes | 1 | 2020 | 98 | 0.140 |
Why?
|
| Doxorubicin | 1 | 2018 | 78 | 0.140 |
Why?
|
| Nanotubes, Carbon | 1 | 2018 | 50 | 0.130 |
Why?
|
| Glioblastoma | 1 | 2018 | 110 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 304 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2017 | 31 | 0.130 |
Why?
|
| Skin | 1 | 2018 | 157 | 0.130 |
Why?
|
| Nanostructures | 1 | 2017 | 64 | 0.120 |
Why?
|
| Stroke | 1 | 2019 | 261 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 315 | 0.110 |
Why?
|
| Inflammation | 1 | 2017 | 670 | 0.090 |
Why?
|
| Nanotechnology | 2 | 2020 | 68 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2019 | 108 | 0.070 |
Why?
|
| Drug Carriers | 2 | 2019 | 119 | 0.070 |
Why?
|
| Apoptosis | 2 | 2021 | 784 | 0.060 |
Why?
|
| Streptozocin | 1 | 2021 | 11 | 0.040 |
Why?
|
| Drug Approval | 1 | 2021 | 12 | 0.040 |
Why?
|
| Nucleic Acids | 1 | 2020 | 10 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 4867 | 0.040 |
Why?
|
| Nootropic Agents | 1 | 2019 | 4 | 0.040 |
Why?
|
| PC12 Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 14 | 0.040 |
Why?
|
| Cations | 1 | 2018 | 11 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 278 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2018 | 32 | 0.040 |
Why?
|
| Skin Absorption | 1 | 2018 | 2 | 0.030 |
Why?
|
| Particle Size | 1 | 2018 | 105 | 0.030 |
Why?
|
| Drug Liberation | 1 | 2018 | 29 | 0.030 |
Why?
|
| Proteins | 1 | 2020 | 256 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 137 | 0.030 |
Why?
|
| Administration, Ophthalmic | 1 | 2017 | 8 | 0.030 |
Why?
|
| Polymers | 1 | 2018 | 118 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1012 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 789 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 705 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2017 | 99 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1684 | 0.030 |
Why?
|
| Rats | 1 | 2019 | 1595 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1362 | 0.030 |
Why?
|